Drug recall D-0314-2021
Product
Tremfya (guselkumab) Injection, 100 mg/mL, one single-dose prefilled syringe per carton, Rx only, Manufactured by: Janssen Biotech, Inc., Horsham, PA 19044; NDC 57894-640-01.
Reason for recall
Temperature Abuse
Lots and codes
KESOY.AI Exp. 04/2022
Recall details
- Recalling firm
- Cardinal Health Inc., Dublin, OH
- Quantity
- 48 boxes
- Distribution
- AL, LA, MS, TN
- Type
- Voluntary: Firm initiated
- Recall initiated
- March 9, 2021
- Terminated
- November 4, 2021
Related products
- Tremfya – drug information
- NDC 57894-650 Tremfya · Guselkumab 200 mg/20mL · Janssen Biotech, Inc.
- NDC 57894-640 Tremfya · Guselkumab 100 mg/mL · Janssen Biotech, Inc.
- NDC 57894-651 Tremfya · Guselkumab 200 mg/2mL · Janssen Biotech, Inc.